Back to Conditions

Anastrozole: How It Differs From Tamoxifen

Anastrozole: How It Differs From Tamoxifen
Prescription Medicines Editorial 24 February 2026

Anastrozole is an aromatase inhibitor, used in hormone-receptor-positive breast cancer. It blocks the enzyme that converts androgens into oestrogen in fat, muscle and other tissues outside the ovaries. That is a different approach from tamoxifen, which blocks the oestrogen receptor rather than reducing the supply - and the difference explains both why anastrozole works better after the menopause and why it does not work before it.

Follow the plan your oncology team gave you. This guide contains no doses.

Why it only works after the menopause

Before the menopause, the ovaries produce most of a woman's oestrogen directly, and they are not controlled by aromatase.

Blocking aromatase in a premenopausal woman therefore lowers oestrogen only partially, and the fall triggers the pituitary to drive the ovaries harder - which can increase oestrogen production and stimulate the ovaries.

After the menopause the ovaries have stopped, and almost all remaining oestrogen comes from aromatase activity elsewhere. Blocking it then reduces oestrogen to very low levels.

Aromatase inhibitors are used in premenopausal women only when ovarian function is also suppressed, with injections or surgery.

Compared with tamoxifen

In postmenopausal women, aromatase inhibitors reduce recurrence somewhat more than tamoxifen. The trade-off is a different side effect profile:

Anastrozole causes more joint and muscle pain, bone loss and fractures, and vaginal dryness.

Tamoxifen causes more blood clots, endometrial cancer, and hot flushes in some comparisons.

Many people take one then switch to the other partway through, which captures some of each benefit. Our guide to tamoxifen covers the alternative, including the antidepressant interaction that does not apply to anastrozole.

Joint pain is the main problem

Aching joints, stiffness - particularly first thing in the morning - and muscle pain affect a large proportion of people taking it, and it is the commonest reason for stopping early.

It usually appears within the first few months. Things that help: regular movement and exercise, which is counter-intuitive when everything aches but has reasonable evidence; simple pain relief; and sometimes switching to a different aromatase inhibitor, since people who cannot tolerate one can often manage another.

Vitamin D deficiency makes it worse and is worth correcting - see cholecalciferol.

Do not simply stop. Stopping early reduces the protection against recurrence, and there are options - tell your team rather than quietly discontinuing.

Bone density

Lowering oestrogen to very low levels accelerates bone loss, and fracture risk rises.

A DEXA bone density scan is usually arranged before starting and repeated during treatment. Calcium and vitamin D are commonly recommended, and a bisphosphonate is added where bone density is low.

Bisphosphonates given for this reason may also reduce breast cancer recurrence in postmenopausal women, which is a useful double benefit. See alendronate and medicines and bone health.

Weight-bearing exercise and stopping smoking both help.

Other side effects

Hot flushes and sweats, though often less troublesome than with tamoxifen. Vaginal dryness and reduced libido, which are common and under-reported - vaginal moisturisers and lubricants help, and low-dose vaginal oestrogen is sometimes used after specialist discussion.

Tiredness, mood changes, hair thinning, raised cholesterol and nausea also occur.

Report significant joint pain, new bone pain, or any symptom that is affecting whether you can keep taking it.

How long

Typically five years, and often extended to ten where risk is higher, since the benefit continues.

Adherence over that period is the practical challenge. Roughly speaking, a substantial minority of people stop early, mostly because of joint symptoms - and that reduces the protection the treatment was for.

Interactions

Anastrozole has few interactions, which is one advantage over tamoxifen.

The important one is the opposite direction: do not take oestrogen, including HRT, while on an aromatase inhibitor - it directly opposes the treatment. See estradiol.

Tamoxifen and anastrozole should not be taken together.

Letrozole and exemestane

Letrozole works in the same way and is used interchangeably in many situations. Exemestane binds the enzyme irreversibly and is sometimes used after one of the others.

Switching between them for side effects is common and often successful - not tolerating one does not mean not tolerating the class.

Anastrozole for prevention

It is also offered to postmenopausal women at high risk of breast cancer who have not had it, typically for five years, where it substantially reduces the chance of developing the disease.

That conversation is different because the person is well, so the side effect burden weighs more heavily. Report anything troublesome through the Yellow Card scheme as well as to your team - see how Yellow Card works.

More on what medicines are prescribed for in the Conditions section, including Atomoxetine: The Non-Stimulant ADHD Option.